SK Bioscience Co Ltd
KRX:302440

Watchlist Manager
SK Bioscience Co Ltd Logo
SK Bioscience Co Ltd
KRX:302440
Watchlist
Price: 46 200 KRW -3.04%
Market Cap: 3.6T KRW
Have any thoughts about
SK Bioscience Co Ltd?
Write Note

SK Bioscience Co Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SK Bioscience Co Ltd
Cash from Financing Activities Peer Comparison

Comparables:
068270
H
145020
P
214450
196170
A
298380

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
SK Bioscience Co Ltd
KRX:302440
Cash from Financing Activities
-â‚©89.6B
CAGR 3-Years
-288%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Cash from Financing Activities
-â‚©273.9B
CAGR 3-Years
N/A
CAGR 5-Years
-8%
CAGR 10-Years
-18%
H
Hugel Inc
KOSDAQ:145020
Cash from Financing Activities
-â‚©232.3B
CAGR 3-Years
-204%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Cash from Financing Activities
-â‚©17.7B
CAGR 3-Years
N/A
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Cash from Financing Activities
â‚©33.2B
CAGR 3-Years
-42%
CAGR 5-Years
39%
CAGR 10-Years
N/A
A
ABL Bio Inc
KOSDAQ:298380
Cash from Financing Activities
â‚©1.8B
CAGR 3-Years
39%
CAGR 5-Years
-52%
CAGR 10-Years
N/A

See Also

What is SK Bioscience Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-89.6B KRW

Based on the financial report for Dec 31, 2023, SK Bioscience Co Ltd's Cash from Financing Activities amounts to -89.6B KRW.

What is SK Bioscience Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-288%

Over the last year, the Cash from Financing Activities growth was -351%. The average annual Cash from Financing Activities growth rates for SK Bioscience Co Ltd have been -288% over the past three years .

Back to Top